Endocrine Society Spotlights Latest Care and Treatment of Type 1 Diabetes
Endocrine Society awarded two-year $268K grant from Leona M. and Harry B. Helmsley Charitable Trust to educate healthcare providers
Source Newsroom: Endocrine Society
Newswise — Washington, DC—The Endocrine Society will host a new educational conference for endocrine fellows on type 1 diabetes. The Endocrine Fellows Conference: Type 1 Diabetes Care and Management, funded by a two-year grant totaling $268K from the Leona M. and Harry B. Helmsley Charitable Trust, will cover the spectrum of diabetes care, from pathophysiology to patient/caregiver counseling to complications and comorbidities.
Type 1 diabetes, sometimes called insulin-dependent diabetes and juvenile diabetes, can develop at any age but most often occurs in children, teens, and young adults. In type 1 diabetes, a person’s pancreas produces little or no insulin, so insulin treatment is needed for a lifetime.
The grant from the Helmsley Trust also includes support for abstract awards and scientific sessions on type 1 diabetes at ICE/ENDO 2014 and ENDO 2015. ENDO, the annual meeting of the Endocrine Society, draws more than 9,000 clinicians and scientists from around the world and focuses attention on diabetes and other hormone disorders.
The Endocrine Fellows Conference: Type 1 Diabetes Care and Management will be held on June 18-20, 2014.
For more information on the fellows conference, go to:
# # #
Founded in 1916, the Endocrine Society is the world’s oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, the Endocrine Society’s membership consists of over 17,000 scientists, physicians, educators, nurses and students in more than 100 countries. Society members represent all basic, applied and clinical interests in endocrinology. The Endocrine Society is based in Washington, DC. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on Twitter at https://twitter.com/#!/EndoMedia.